Gene Silencing via PDA/ERK2-siRNA-Mediated Electrospun Fibers for Peritendinous Antiadhesion.
adhesion prevention
adhesion tissue formation
electrospun fibers
gene delivery
siRNA
Journal
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569
Informations de publication
Date de publication:
23 Jan 2019
23 Jan 2019
Historique:
received:
27
07
2018
revised:
30
09
2018
entrez:
30
1
2019
pubmed:
30
1
2019
medline:
30
1
2019
Statut:
epublish
Résumé
Sustained delivery of small interfering RNA (siRNA) is a challenge in gene silencing for managing gene-related disorders. Although nanoparticle-mediated electrospun fibers enable sustainable gene silencing, low efficiency, loss of biological activity, toxicity issues, and complex electrospinning techniques are all bottlenecks of these systems. Preventing peritendinous adhesion is crucial for their successful use, which involves blocking cellular signaling via physical barriers. Here, a multifunctional, yet structurally simple, cationic 2,6-pyridinedicarboxaldehyde-polyethylenimine (PDA)-mediated extracellular signal-regulated kinase (ERK)2-siRNA polymeric delivery system is reported, in the form of peritendinous antiadhesion electrospun poly-l-lactic acid/hyaluronan membranes (P/H), with the ability to perform sustained release of bioactive siRNA for long-term prevention of adhesions and ERK2 silencing. After 4 days of culture, the cell area and proliferation rate of chicken embryonic fibroblasts on siRNA+PDA+P/H membrane are significantly less than those on P/H and siRNA+P/H membranes. The in vivo results of average optical density of collagen type III (Col III) and gene expression of ERK2 and its downstream SMAD3 in the siRNA+PDA+P/H group are less than those of P/H and siRNA+P/H groups. Consequently, siRNA+PDA+P/H electrospun membrane can protect the bioactivity of ERK2-siRNA and release it in a sustained manner. Moreover, adhesion formation is inhibited by reducing fibroblast proliferation and Col III deposition, and downregulating ERK2 and its downstream SMAD3.
Identifiants
pubmed: 30693181
doi: 10.1002/advs.201801217
pii: ADVS870
pmc: PMC6343062
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1801217Références
Methods Mol Biol. 2009;487:221-42
pubmed: 19301650
Mol Pharm. 2015 Feb 2;12(2):621-9
pubmed: 25591125
J Intern Med. 2010 Jan;267(1):44-53
pubmed: 20059643
PLoS One. 2012;7(9):e44295
pubmed: 22962608
J Control Release. 2017 Oct 28;264:1-13
pubmed: 28803898
J Hand Surg Am. 2010 Jun;35(6):941-7
pubmed: 20513575
Nanomedicine (Lond). 2012 Dec;7(12):1851-62
pubmed: 22943129
Biomaterials. 2010 May;31(14):4009-16
pubmed: 20149434
J Hand Surg Am. 1994 Jan;19(1):61-9
pubmed: 7726882
Biomaterials. 2015 Aug;61:61-74
pubmed: 25996412
Int J Pharm. 2016 May 17;504(1-2):125-33
pubmed: 27036397
J Hand Surg Am. 2002 Mar;27(2):293-306
pubmed: 11901389
Int J Mol Sci. 2013 Feb 21;14(2):4361-71
pubmed: 23429276
J Exp Clin Cancer Res. 2016 Mar 31;35:57
pubmed: 27029190
J Control Release. 2010 Jun 1;144(2):203-12
pubmed: 20138939
Mol Pharmacol. 2006 Dec;70(6):1992-2003
pubmed: 16959941
Acta Biomater. 2013 Jul;9(7):7381-8
pubmed: 23567943
Inflamm Res. 2004 Aug;53(8):355-62
pubmed: 15316666
J Orthop Res. 2000 Mar;18(2):212-9
pubmed: 10815821
Sci Rep. 2016 Oct 19;6:35661
pubmed: 27759095
Am J Pathol. 2003 Aug;163(2):621-32
pubmed: 12875981
Biomacromolecules. 2012 Nov 12;13(11):3611-9
pubmed: 23025492
Adv Drug Deliv Rev. 2015 Jun 29;87:108-19
pubmed: 25666164
Hand (N Y). 2015 Sep;10(3):482-8
pubmed: 26330782
J Am Chem Soc. 2009 Jul 8;131(26):9204-6
pubmed: 19530653
Biochem Biophys Res Commun. 2009 May 1;382(2):259-63
pubmed: 19285964
Biomaterials. 2013 Jun;34(19):4690-701
pubmed: 23541108
Int J Mol Sci. 2008 Jun;9(6):978-999
pubmed: 19325841
Ann Plast Surg. 2018 Feb;80(2):171-175
pubmed: 28671883
ACS Nano. 2012 Jun 26;6(6):4835-44
pubmed: 22621383
Tissue Eng Part A. 2013 Feb;19(3-4):529-37
pubmed: 23013368
J Hand Surg Am. 2009 Dec;34(10):1777-84.e1
pubmed: 19969188
Biomaterials. 2012 Feb;33(4):1154-61
pubmed: 22061489
Methods Mol Biol. 2016;1364:143-50
pubmed: 26472448
Sci Rep. 2017 Aug 17;7(1):8658
pubmed: 28819185
Macromol Biosci. 2015 Oct;15(10):1457-68
pubmed: 26096875
Int J Nanomedicine. 2012;7:1399-414
pubmed: 22457597
Biomaterials. 2015 Jan;37:94-106
pubmed: 25453941
Nat Biotechnol. 2017 Mar;35(3):222-229
pubmed: 28244992
J Hand Surg Am. 2013 Jun;38(6):1071-8
pubmed: 23660197
J Hand Microsurg. 2015 Dec;7(2):244-9
pubmed: 26578825
J Mater Sci Mater Med. 2015 Feb;26(2):101
pubmed: 25655500
Carbohydr Polym. 2015 Mar 6;117:324-330
pubmed: 25498642
J Bone Joint Surg Am. 2011 Jan 19;93(2):142-9
pubmed: 21248211
Methods Mol Biol. 2009;480:65-83
pubmed: 19085118
Biochem Biophys Res Commun. 2010 Jan 1;391(1):795-9
pubmed: 19958750
J Allergy Clin Immunol. 2007 Jun;119(6):1388-97
pubmed: 17418380
Balkan Med J. 2016 May;33(3):258-66
pubmed: 27308069
Int J Nanomedicine. 2016 Jun 22;11:2873-81
pubmed: 27382278
Expert Opin Drug Deliv. 2016;13(3):373-87
pubmed: 26634750
Biomaterials. 2014 Mar;35(9):3071-9
pubmed: 24397987
Adv Sci (Weinh). 2018 Nov 20;6(2):1801217
pubmed: 30693181
Gene Ther. 2016 Feb;23(2):167-75
pubmed: 26381218
Biomaterials. 2014 Dec;35(37):9920-9929
pubmed: 25201739
Acta Biomater. 2013 Jan;9(1):4513-24
pubmed: 23036951
Int J Nanomedicine. 2017 Mar 28;12:2385-2405
pubmed: 28405163
Expert Opin Drug Deliv. 2016;13(4):547-59
pubmed: 26735861
Acta Biomater. 2016 Apr 15;35:98-108
pubmed: 26873365
J Hand Surg Eur Vol. 2014 Jan;39(1):60-70
pubmed: 24162452
Nucleic Acids Res. 2010 Jul;38(13):4547-57
pubmed: 20413581
Sci Transl Med. 2014 Jun 11;6(240):240ps7
pubmed: 24920658
Biomaterials. 2011 Sep;32(25):5915-23
pubmed: 21596430